MM 014
Latest Information Update: 14 Jul 2010
At a glance
- Originator Merrimack Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 25 Aug 2003 Preclinical trials in Cancer in USA (unspecified route)